Usefulness of serum des-gamma-carboxy prothrombin in detection of hepatocellular carcinoma - Wikidata - wikimedia - TriplyDB

Usefulness of serum des-gamma-carboxy prothrombin in detection of hepatocellular carcinoma

Usefulness of serum des-gamma-carboxy prothrombin in detection of hepatocellular carcinoma

http://www.wikidata.org/entity/Q35621312

about

Tumor markers for hepatocellular carcinoma (Review)Tissue- and Serum-Associated Biomarkers of Hepatocellular Carcinoma Diagnostic Performance of Des-γ-carboxy Prothrombin for Hepatocellular Carcinoma: A Meta-Analysis Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma.Early diagnostic potential for hepatocellular carcinoma using the SELDI ProteinChip system.Tumor and liver determinants of prognosis in unresectable hepatocellular carcinoma: a large case cohort study.Evaluation of individual and combined applications of serum biomarkers for diagnosis of hepatocellular carcinoma: a meta-analysis.Clinical utility of protein induced by vitamin K absence in patients with chronic hepatitis B virus infection Assessment of the correlation between serum prolidase and alpha-fetoprotein levels in patients with hepatocellular carcinoma.Utility of serum des-gamma-carboxyprothrombin in the diagnosis of hepatocellular carcinoma among Nigerians, a case-control study Quantitative proteomic analysis for high-throughput screening of differential glycoproteins in hepatocellular carcinoma serum.Diagnostic value of AFP-L3 and PIVKA-II in hepatocellular carcinoma according to total-AFP.Value of α-fetoprotein in association with clinicopathological features of hepatocellular carcinoma A Systematic Review of Des-γ-Carboxy Prothrombin for the Diagnosis of Primary Hepatocellular Carcinoma.Efficacy of PIVKA-II in prediction and early detection of hepatocellular carcinoma: a nested case-control study in Chinese patients.An overview of hepatocellular carcinoma study by omics-based methods.Clinical and molecular insights into the hepatocellular carcinoma tumour marker des-γ-carboxyprothrombin.Diagnostic accuracy of des-gamma-carboxy prothrombin versus α-fetoprotein for hepatocellular carcinoma: A systematic review.Proteomic profiling of N-linked glycoproteins identifies ConA-binding procathepsin D as a novel serum biomarker for hepatocellular carcinoma.Tumor and liver determinants of prognosis in unresectable hepatocellular carcinoma: a case cohort study.Combining des-gamma-carboxyprothrombin and alpha-fetoprotein for hepatocellular carcinoma diagnosing: an update meta-analysis and validation study.Evaluation of alpha-fetoprotein in detecting hepatocellular carcinoma recurrence after radiofrequency ablation.Ubiquitin-proteasome profiling for enhanced detection of hepatocellular carcinoma in patients with chronic liver disease.Intrahepatic splenosis mimics hepatocellular carcinoma in a patient with chronic hepatitis B: A case report and literature review.Intrahepatic splenosis mimics hepatocellular carcinoma in a patient with chronic hepatitis B: A case report and literature review.Clinical usefulness of double biomarkers AFP and PIVKA-II for subdividing prognostic groups in locally advanced hepatocellular carcinoma.Prognostic value of plasma fibrinogen in hepatocellular carcinoma: a meta-analysis

P2860

Q24608195-6E6B4C85-CD5F-4EE2-967B-0E0DD5ED7AEC Q26743361-E2AE390E-13B0-4618-8C2B-505F3CF584C6 Q26863560-08786CEE-07D4-4854-B037-B6ECF0EBC4B7 Q30479629-EAB3E44D-FB2D-40F6-A19C-681D4613F032 Q33280446-49AC8849-D0A2-4E64-8E50-37C457DCBF82 Q33718951-48E09B16-46A9-411E-95C3-E20DC7A4BD87 Q35062428-591703A1-B66F-4231-BEA1-25C97E93F305 Q35125611-3606A383-4571-4791-8D3C-EABD3F23C325 Q35716344-DAF38261-6CB1-4F7B-A378-E6F5FD14609F Q35764990-4A64819D-79EC-4D59-9B20-86F85BEF5756 Q36167811-37BF5BD7-6E56-4729-9ABE-C59C29764CC0 Q36561639-BB81F7A5-388E-475D-9734-EFA67F32BC15 Q36715087-A43F7D01-F8C7-4750-B767-77C9E4E4D0A2 Q37206392-820B329D-70DF-4B86-9161-A12939CF0782 Q37330554-7BA587BE-6A00-4AD3-AB64-65A3814AA837 Q37364456-24FE38F9-2F50-4589-AA24-EE015870A482 Q37793324-5B95FE4B-1D89-4462-B9DF-3EC34EAF4489 Q38120063-5C2A5E52-A98A-4A75-A4AB-A83083BFE16D Q39060093-30F66B20-B075-43B5-9CCF-9D985749B6EE Q44819694-345A66B1-B9F4-40B5-BC83-85D34247E6D3 Q45465312-D41DDDD0-6EB0-4BDC-8777-28860BFE0F25 Q46035308-CA5601AA-34FB-4915-8A7F-2A7B66C16BE2 Q46056334-AEA391F7-4DEE-488F-8D72-9D836639F166 Q47130268-1809F651-8CB6-4284-A532-5005971F9531 Q47547874-45449B72-F18C-47F3-A418-52A289558728 Q47911866-D8A54178-79F2-4322-AD3E-053A66153BAD Q59135332-C3C0B3C8-4555-4D88-8A45-40C43345860B

P2860

Usefulness of serum des-gamma-carboxy prothrombin in detection of hepatocellular carcinoma

http://www.wikidata.org/entity/Q35621312

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Usefulness of serum des-gamma- ...... on of hepatocellular carcinoma

@ast

Usefulness of serum des-gamma- ...... on of hepatocellular carcinoma

@en

type

label

Usefulness of serum des-gamma- ...... on of hepatocellular carcinoma

@ast

Usefulness of serum des-gamma- ...... on of hepatocellular carcinoma

@en

prefLabel

Usefulness of serum des-gamma- ...... on of hepatocellular carcinoma

@ast

Usefulness of serum des-gamma- ...... on of hepatocellular carcinoma

@en

P1433

Q35621312-936132FA-EA1C-4332-ACB3-057CA25A5541

P1476

Q35621312-4AE13E5D-382D-4CE3-AF6C-0B2EAB60733A

P2093

Q35621312-19EEA182-BABE-47D5-BD4E-6FFD07CDE6DE

Q35621312-5E1D89FC-E4D5-40E8-9EDA-EA410679AFE8

Q35621312-63387C0C-F0C6-48F8-8053-0374E76474DB

Q35621312-674BF6D8-EAD8-49EA-A907-EE0DF80F4E28

Q35621312-8DF25C08-FA23-4D9C-8B6F-FECEEE29509B

Q35621312-9EECFC0E-C9AA-4086-8832-36A7795ECD93

Q35621312-D7B95D34-5E8F-4345-B467-A080347E8731

Q35621312-E753C0D7-CBC2-4DC7-A0B8-5F42AE0181E0

P2860

Q35621312-1B97E296-3FC3-4D18-B9C3-55276465AE61

Q35621312-22F1AD60-866C-4CD2-8C6B-FFD317FF058A

Q35621312-314FD775-B889-4384-827B-7C9943EF3827

Q35621312-51A064C7-8514-4339-8095-EF4D58F07DD4

Q35621312-56B3993B-4E83-4D18-9178-3498248F2424

Q35621312-72373234-28EE-4E6E-B933-840E1693F4D2

Q35621312-838FFCE5-AC05-4D41-A7F8-91E310BFD206

Q35621312-86A9A5EA-228E-4CBD-8F5F-AE4A55220839

Q35621312-87BF27D4-6350-468C-9E73-EAFF1AE2D9F2

Q35621312-90623E97-ADFD-498B-808F-9F3302D1E1F5

P304

Q35621312-A28CFCF3-D247-48CF-87DF-0E1031DDB3D7

P31

Q35621312-DC0C67E0-2896-48A1-991F-ACBCCA373DD8

P356

Q35621312-D473C95E-919E-4AFB-9DF2-9B5B8D5EFEF9

P407

Q35621312-0E3640B1-6F13-4FAB-A755-7A7AA062E14A

P433

Q35621312-CE9FA3A7-6713-4D15-B34B-9A0FCBF8E7D3

P478

Q35621312-4DEB1FF7-AA9D-49E0-9413-86E27DE638B6

P577

Q35621312-93E15FA0-1CEB-4986-8AEA-861176451FA3

P698

Q35621312-D6EA30EF-CB7B-4AE6-9D4B-0407E4D36103

P932

Q35621312-F4ABC0C6-0093-4729-AFDB-9316A4FB1210

P356

WJG.V11.I39.6115

P1433

World Journal of Gastroenterology

P1476

Usefulness of serum des-gamma- ...... on of hepatocellular carcinoma

@en

P2093

Chaur-Shine Wang

http://www.w3.org/2001/XMLSchema#string

Chih-Lin Lin

http://www.w3.org/2001/XMLSchema#string

Hsi-Chang Lee

http://www.w3.org/2001/XMLSchema#string

Hung-Sheng Chen

http://www.w3.org/2001/XMLSchema#string

Kuan-Yang Chen

http://www.w3.org/2001/XMLSchema#string

Li-Ying Liao

http://www.w3.org/2001/XMLSchema#string

Ming-Feng Chiang

http://www.w3.org/2001/XMLSchema#string

Tsung-Jung Lin

http://www.w3.org/2001/XMLSchema#string

P2860

Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients

Plasma des-gamma-carboxyprothrombin in the early stage of hepatocellular carcinoma

Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

Primary liver cancer: worldwide incidence and trends

Epidemiology of primary liver cancer.

Transection of the oesophagus for bleeding oesophageal varices.

Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status.

Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications

Production of embryonal serum alpha-globulin by hepatomas: review of experimental and clinical data.

P304

6115-6119

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V11.I39.6115

http://www.w3.org/2001/XMLSchema#string

P407

P433

39

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2005-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16273636

http://www.w3.org/2001/XMLSchema#string

P932

4436626

http://www.w3.org/2001/XMLSchema#string